 |
 |
Delete by looking at the subject line and without reading - it is the reading that takes the time. That is what I do with the political discussions that do not concern me at all. Moneesha 2009/9/13 carl grame <[log in to unmask]> > I do delete all of them but that takes time. Is there any other option? > > On Sat, Sep 12, 2009 at 4:31 AM, Kathleen Cochran <[log in to unmask]> > wrote: > > If you don't want to read it, delete it. End of story. > > > > 2009/9/11 carl grame <[log in to unmask]> > > > >> I don't look at any of your emails, there are just too many from you. > >> What else do you do? > >> > >> On Thu, Sep 10, 2009 at 8:43 PM, rayilynlee <[log in to unmask]> wrote: > >> > 9th September 2009 - New research > >> > THE EFFECT OF ROPINIROLE (REQUIP) ON PARKINSON'S DISEASE > >> > > >> > Clinical neurology and neurosurgery [2009] Sep 2 [Epub ahead of print] > >> > (Valldeoriola F, Cobaleda S, Lahuerta J.) Complete abstract > >> > > >> > Ropinirole is a dopamine agonist that is commonly used in the > treatment > >> of > >> > Parkinson's Disease. It is often sold as Requip, Ropark, or Adartrel. > For > >> > more information go to Ropinirole. Ropinirole was found to be mostly > used > >> as > >> > an add on treatment (in 76% of cases), and as the only treatment in > >> around a > >> > quarter (24%) of those people using it. The average maintenance dose > was > >> > found to be 9mg per day, and normally be within the range 4mg to 15mg. > >> Over > >> > a quarter (28%) of people taking Ropinirole reported adverse > reactions. > >> The > >> > most frequent adverse reactions were somnolence and sedation (9%), > >> > gastrointestinal symptoms (7%), increase in dyskinesia (6%), and > >> orthostatic > >> > symptoms (4%). Treatment using Ropinirole was withdrawn in 14% of > >> patients, > >> > largely because of either adverse reactions, lack of efficacy, or > change > >> in > >> > treatment. Over 80% of people taking Ropinirole were considered by > their > >> > neurologists to have improved after taking it. In order to refer to > this > >> > article on its own click here. > >> > > >> > 5th September 2009 - New research > >> > RETINAL STEM CELLS DISAPPEAR AFTER SURGERY FOR PARKINSON'S DISEASE > >> > > >> > Neurology [2009] Sep 2. [Epub ahead of print] (Farag ES, Vinters HV, > >> > Bronstein J.) Complete abstract > >> > > >> > Retinal pigment epithelial cells have been found to disappear after > being > >> > used in a form of surgery intended for use in Parkinson's Disease. For > >> > years, the use of implanted stem cells have been claimed to have the > >> > potential to rid Parkinson's Disease. One of these means is the use > of > >> RPE > >> > (retinal pigment epithelium) cells. These cells are found in the eyes > and > >> > can also produce dopamine, the substance whose deficiency causes > >> Parkinson's > >> > Disease. A 68-year-old man underwent surgical implantation of 325,000 > RPE > >> > cells in Spheramine (gelatin microcarriers) for the treatment of > >> Parkinson's > >> > Disease. He happened to die six months after the surgery took place. > This > >> > enabled the researchers to see what happened to retinal stem cells > after > >> > surgical implantation. Over 99.9% of the cells had disappeared after > only > >> > six months. Implanted cells simply failed to survive. A previous study > >> using > >> > the same methods demonstrated only a moderate benefit for six months. > For > >> > more details see the Complete abstract. Despite different forms of > stem > >> cell > >> > surgery now being carried out in countries around the world, there is > not > >> > even one study in the entire medical literature showing that anybody > has > >> > ever been rid of Parkinson's Disease by this means. In order to refer > to > >> > this article on its own click here. > >> > > >> > Rayilyn Brown > >> > Director AZNPF > >> > Arizona Chapter National Parkinson Foundation > >> > [log in to unmask] > >> > ---------------------------------------------------------------------- > >> > To sign-off Parkinsn send a message to: mailto: > >> [log in to unmask] > >> > In the body of the message put: signoff parkinsn > >> > > >> > >> ---------------------------------------------------------------------- > >> To sign-off Parkinsn send a message to: mailto: > >> [log in to unmask] > >> In the body of the message put: signoff parkinsn > >> > > > > ---------------------------------------------------------------------- > > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > > In the body of the message put: signoff parkinsn > > > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn